In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against coryneform bacteria

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3290-3292

  Martínez Martínez, Luis ^a,b,c   Pascual, Alvaro ^a,b   Suárez, Ana Isabel ^a   Perea, Evelio J ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b School of Medicine   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; MACROLIDE; TELITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BREVIBACTERIUM; CORYNEBACTERIUM; CORYNEBACTERIUM UREALYTICUM; LISTERIA MONOCYTOGENES; NONHUMAN; PRIORITY JOURNAL;

EID: 0345451026     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3290     Document Type: Article

References (15)

1. Bryskier, A., C. Agouridas, and J. F. Chantot. 1997. Ketolide: new semisynthetic 14-membered ring macrolide, p. 39-50. In S. H. Zinner, L. S. Young, J. P. Acar, and H. C. Neu (ed.), Expanding indications for the new macrolides, azalides and streptogramins. Marcel Dekker Inc., New York, N.Y.
2. Collins, M. D., R. A. Burton, and D. Jones. 1988. Corynebacterium amycolatum sp. nov., a new mycolic acid-less Corynebacterium species from human skin. FEMS Microbiol. Lett. 49:349-352.
3. García-Rodríguez, J. A., J. E. García Sánchez, J. L. Muñoz Bellido, T. Nebreda Mayoral, E. García Sánchez, and I. García García. 1991. In vitro activity of 79 antimicrobial agents against Corynebacterium group D2. Antimicrob. Agents Chemother. 35:2140-2143.
4. Funke, G., P. A. Lawson, K. A. Bernard, and M. D. Collins. 1996. Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum. J. Clin. Microbiol. 34:1124-1128.
5. Funke, G., V. Pünter, and A. Von Graevenitz. 1996. Antimicrobial susceptibility patterns of some recently established coryneform bacteria. Antimicrob. Agents Chemother. 40:2874-2878.
6. Funke, G., A. von Graevenitz, J. E. Clarridge, and K. A. Bernard. 1997. Clinical microbiology of coryneform bacteria. Clin. Microbiol. Rev. 10:125-159.
7. Jones, R. N., and D. J. Biedenbach. 1997. Antimicrobial activity of RU-66647, a new ketolide. Diagn. Microbiol. Infect. Dis. 27:7-12.
8. Martínez-Martínez, L., A. Pascual, K. Bernard, and A. I. Suárez. 1996. Antimicrobial susceptibility pattern of Corynebacterium striatum. Antimicrob. Agents Chemother. 40:2671-2672.
9. Martínez-Martínez, L. 1998. Clinical significance of newly recognized coryneform bacteria. Rev. Med. Microbiol. 9:55-68.
10. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard. NCCLS document M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
11. Philippon, P., and E. Bimet. 1990. In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 9:892-895.
12. Riegel, P., R. Ruimy, R. Christen, and H. Monteil. 1996. Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources. Eur. J. Clin. Microbiol. Infect. Dis. 15:657-662.
13. Soriano, F., C. Ponte, M. Santamaría, A. Torres, and R. Fernández-Roblas. 1987. Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid. J. Antimicrob. Chemother. 20:349-355.
14. Soriano, F., J. Zapardiel, and E. Nieto. 1995. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob. Agents Chemother. 39:208-214.
15. Soriano, F., R. Calvo, and R. Fernández-Roblas. 1997. In vitro activity of ketolide HMR 3647 (RU 66647) against grampositive bacilli, abstr. F-118, p. 166. In Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.